The role of the CCR1 receptor in the inflammatory response to tobacco smoke in a mouse model

Inflammation Research

Volumn 59, Issue 10, 2010, Pages 817-825

  Önnervik, Per Ola ^a   Lindahl, Maria ^a   Svitacheva, Naila ^a   Stämpfli, Martin ^a,b   Thim, Kerstin ^a   Smailagic, Amir ^a   Virtala, Robert ^a   Taylor, John D ^a  

^a ASTRAZENECA R AND D   (Sweden)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

C chemokine receptor 1; Chronic obstructive pulmonary disease; Steroid; Tobacco smoke induced inflammation

Indexed keywords

CHEMOKINE RECEPTOR CCR1; GELATINASE B; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LEUKEMIA INHIBITORY FACTOR; LIPOPOLYSACCHARIDE; MACROPHAGE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; STEROID; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BAGG ALBINO MOUSE; CIGARETTE SMOKING; CONTROLLED STUDY; EXUDATE; FEMALE; GENE EXPRESSION; INFLAMMATORY DISEASE; LUNG INFILTRATE; MOUSE; NEUTROPHILIA; NONHUMAN; PATHOGENESIS; PNEUMONIA;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; GENE EXPRESSION; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; RECEPTORS, CCR1; SMOKE; STEROIDS; TOBACCO;

EID: 77956938867     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-010-0193-5     Document Type: Article

References (41)

1. G Vigei F Pistelli DL Sherill S Maio S Baldicci L Carrozzi 2007 Definition, epidemiology and natural history of COPD Eur Respir J 30 993 1013 10.1183/09031936.00082507 (Pubitemid 351194805)
2. O'Byrne PM. Exacerbation of asthma & COPD: definitions, clinical manifestations & epidemiology. In: Sjöbring U, Taylor JD, editors. Models of exacerbations in asthma & COPD: contributions to microbiology, vol. 14. Karger: Basel; 2007. p. 1-11.
3. R Rodriguez-Roisin 2000 Toward a consensus definition or COPD exacerbation Chest 117 5 Suppl 2 398S 401S 1:STN:280:DC%2BD3czgsFCmsg%3D%3D 10.1378/chest.117.5-suppl-2.398S 10843984
4. S Burge JA Wedzicha 2003 COPD exacerbations: definitions and classifications Eur Respir J 41 46s 53s 1:STN:280:DC%2BD3s3mvVyqsg%3D%3D 10.1183/09031936.03.00078002
5. JA Wedzicha T Seemungal 2007 COPD exacerbations: defining their cause and prevention Lancet 370 786 796 10.1016/S0140-6736(07)61382-8 17765528 (Pubitemid 47320802)
6. Gashler GJ, Skrtic M, Zavitz CCJ, Lindahl M, Önnervik PO, Murphy TF, Sethi S, Stampfli MR. Bacteria challenge in smoke exposed mice exacerbates inflammation and skews the inflammatory profile. Am J Respir Crit Care Med. 2009. doi: 10.1164/rccm.200808-1306OC.
7. P Broberg 2003 Statistical methods for ranking differentially expressed genes Genome Biol 4 R41 10.1186/gb-2003-4-6-r41 12801415
8. S Shapiro D DeMeo EK Silverman 2004 Smoke and mirrors. Mouse models as a reflection of human chronic obstructive pulmonary disease Am J Respir Crit Care 170 929 931 10.1164/rccm.2408007 (Pubitemid 39425685)
9. MF Fitzgerald CJ Cox 2007 Emerging trends in the therapy of COPD: novel anti-inflammatory agents in clinical development Drug Discov Today 12 479 486 1:CAS:528:DC%2BD2sXlvVart7Y%3D 10.1016/j.drudis.2007.04.005 17532533 (Pubitemid 46795591)
10. Churg A, Wright J. Animal models of cigarette smoke-induced COPD. In: Sjöbring U, Taylor JD, editors. Models of exacerbations in asthma & COPD: contributions to microbiology, vol. 14. Karger: Basel; 2007. p. 113-25.
11. G Leclerc V Lagente JM Planquis C Berthelier M Artola T Eicholtz C Bertrand F Schmidlin 2006 Involvement of MMP-12 and PDE4 in cigarette smoke-induced inflammation in mice Eur Respir J 27 1102 1109 1:CAS:528:DC%2BD28XlvF2hsbk%3D 10.1183/09031936.06.00076905 16510458 (Pubitemid 44914292)
12. K Biggadike R Bledsoe A Hassell B Kirk IM McLay L Shewchuk E Stewart 2008 X-ray crystal of the novel enhanced affinity agonist fluticasone furoate in the gluticocorticoid receptor ligand domain J Med Chem 51 12 3349 3352 1:CAS:528:DC%2BD1cXms1Gis7w%3D 10.1021/jm800279t 18522385 (Pubitemid 351874991)
13. S Medicherla M Fitzgerald D Spicer P Woodman J Ma A Kapoun S Chakravarty S Dugar A Protter L Higgins 2008 p38-a Selective mitogen activated protein kinase inhibitor SD-282 reduced inflammation in a subchronic model of TS induced airway inflammation J Pharmacol Exp Ther 324 921 929 1:CAS:528: DC%2BD1cXivVajsrk%3D 10.1124/jpet.107.127092 18056868 (Pubitemid 351397845)
14. MT Amano AS Carneiro OG Ribeiro WK Cabrera M De Franco OM Ibanez L Isacc N Starobinas 2009 A new model of outbred genetically selected mice which present a strong acute inflammatory response in the absence of complement C5 Inflamm Res 58 204 209 1:CAS:528:DC%2BD1MXjsVOmtL0%3D 10.1007/s00011-008-8132-4 19169648
15. T Thatcher N McHugh R Egan R Chapman JA Hey C Turner M Redonnet K Seweryniak P Sime R Phips 2005 Role of CXCR2 in cigarette smoke-induced lung inflammation Am J Physiol Lung Cell Mol Physiol 289 L322 L328 1:CAS:528:DC%2BD2MXotFais70%3D 10.1152/ajplung.00039.2005 15833762 (Pubitemid 41008916)
16. A Sato Y Hoshino T Hara S Muro H Nakamura M Mishima J Yodoi 2008 Thioredoxin-1 ameliorates cigarette smoke-induced lung inflammation and emphysema in mice J Pharmacol Exp Ther 325 380 388 1:CAS:528: DC%2BD1cXlsVOjsLk%3D 10.1124/jpet.107.134007 18256171 (Pubitemid 351574797)
17. AB Thompson D Daughton RA Robbins MA Ghafouri M Oehlerking SI Rennard 1989 Intraluminal airway inflammation in chronic bronchitis. Characterisation and correlation with clinical parameters Am Rev Respir Dis 140 6 1527 1537 1:STN:280:DyaK3c7gtlahsA%3D%3D 2604284
18. JY Lacoste J Bousquet P Chanez T Van Vyve J Simony-Lafontaine N Lequeu P Vic I Enander P Godard FB Michel 1993 Eosinophilic inflammation in asthma, chronic bronchitis and COPD J Allergy Clin Immunol 92 4 537 548 1:STN:280:DyaK2c%2FhsVSitw%3D%3D 10.1016/0091-6749(93)90078-T 8409114 (Pubitemid 23317077)
19. KF Chung 2001 Cytokines in chronic obstructive pulmonary disease Eur Respir J Suppl 34 50s 59s 1:STN:280:DC%2BD38njtlCmtg%3D%3D 10.1183/09031936.01. 00229701 12392035
20. WI DeBoer JK Sont A van Schadewwijk J Stolk JH van Krieken PS Hiemstra 2000 Monocyte chemoattractant protein 1, interleukin 8 and chronic airways inflammation in COPD J Pathol 190 619 626 1:CAS:528:DC%2BD3cXivVSrtL0%3D 10.1002/(SICI)1096-9896(200004)190:5<619::AID-PATH555>3.0.CO;2-6 (Pubitemid 30164493)
21. SL Traves SV Culpitt RE Russell PJ Barnes LE Donnelly 2002 Increased levels of the chemokines GROalpha and MCP-1 in sputum samples from patients with COPD Thorax 57 7 590 595 1:STN:280:DC%2BD38zltlWhug%3D%3D 10.1136/thorax.57.7. 590 12096201 (Pubitemid 34761760)
22. VM Keatings PD Collins DM Scott PJ Barnes 1996 Differences in interleukin-8 and tumour necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma Am J Respir Crit Care Med 153 2 530 534 1:STN:280:DyaK287mtVGmug%3D%3D 8564092
23. P Boschetto S Quintavalle E Zeni S Leprotti A Potena L Ballerin A Papi G Palladini M Luisetti L Annovazzi P Iadarola E De Rosa LM Fabbri CE Mapp 2006 Associated between markers of emphysema and more severe chronic obstructive pulmonary disease Thorax 61 1037 1042 1:STN:280:DC%2BD28nns12lsw%3D%3D 10.1136/thx.2006.058321 16769715 (Pubitemid 44852020)
24. PF Mercer JK Shute A Bhomik GC Donaldson JA Wedzicha JA Warner 2005 MMP-9, TIMP-1 and inflammatory cells in sputum from COPD patients during exacerbations Respir Res 6 1-9 151 1:STN:280:DC%2BD28%2FltFCkug%3D%3D 10.1186/1465-9921-6-151 16372907 (Pubitemid 43040544)
25. JC Hogg RM Senior 2002 Chronic obstructive pulmonary disease-2; pathology and biochemistry of emphysema Thorax 57 830 834 1:STN:280: DC%2BD38vmtlSkug%3D%3D 10.1136/thorax.57.9.830 12200530 (Pubitemid 34984984)
26. W Macnee 2008 Update in chronic obstructive pulmonary disease 2007 Am J Respir Crit Care Med 177 8 820 829 10.1164/rccm.200801-167UP 18390963 (Pubitemid 351600660)
27. S Pierrou P Broberg R O'Donnell K Pawlowski R Virtala E Lindqvist A Richter SJ Wilson G Angco S Möller H Bergstrand W Koopmann E Wieslander PE Strömstedt S Holgate D Daviers J Lund R Djukanovic 2007 Expression of genes involved in oxidative stress responses in airway epithelial cells of smokers with chronic obstructive pulmonary disease Am J Respir Crit Care Med 175 577 586 1:CAS:528:DC%2BD2sXkt1Wgu74%3D 10.1164/rccm.200607-931OC 17158281 (Pubitemid 46438942)
28. H Yao S Yang S Kode S Rajendrasozhan S Caito D Adenuga R Henry I Edirisinghe I Rahman 2007 Redox regulation of lung inflammation: role of NADPH oxidase and NF-kappaB signalling Biochem Soc Trans 35 1151 1155 1:CAS:528:DC%2BD2sXht1eru7vO 10.1042/BST0351151 17956299 (Pubitemid 350206448)
29. Y Qiu J Zhu V Bandi R Atmar K Hattotuwa K Guntupalli P Jeffrey 2003 Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of COPD Am J Respir Crit Care Med 168 968 975 10.1164/rccm.200208-794OC 12857718 (Pubitemid 37267175)
30. S Molet C Belleguic H Lena N Germain CP Bertrand SD Shapiro JM Planqouis P Delaval V Lagenta 2005 Increase in macrophage elastase from patients with COPD Inflamm Res 54 31 36 1:CAS:528:DC%2BD2MXkvVWrtro%3D 10.1007/s00011-004-1319-4 15723202 (Pubitemid 40385338)
31. IA Yang KM Fong EH Sim PN Black TJ Lasserson 2007 Inhaled corticosteroids for stable chronic obstructive pulmonary disease Cochrane Database Syst Rev 18 CD002991
32. S Culpitt W Maziak S Loukidis J Nightingale J Matthews PJ Barnes 1999 Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease Am J Respir Crit Care Med 160 1635 1639 1:STN:280:DC%2BD3c%2FislKqsg%3D%3D 10556133
33. N Alexis D Peden 2001 Blunting airway eosinophilic inflammation results in a decreased airway neutrophil response to inhaled LPS in patients with atopic asthma: a role for CD14 J Allergy Clin Immunol 108 577 580 1:STN:280: DC%2BD3Mrktlymsg%3D%3D 10.1067/mai.2001.118511 11590384 (Pubitemid 32978029)
34. JL Gao TA Wynn Y Chang EJ Lee HE Broxmeyer S Cooper HL Tiffany H Westphal J Kwon-Chung PM Murphy 1997 Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1 J Exp Med 185 1959 1968 1:CAS:528:DyaK2sXjsF2gsL0%3D 10.1084/jem.185.11.1959 9166425 (Pubitemid 27247082)
35. R Gladhue S Zwillich A Clucas M Brown 2004 CCR1 antagonists for the treatment of autoimmune diseases Curr Opin Investig Drugs 5 499 504
36. A Di Stefano A Capelli M Lusuardi P Balbo C Vecchio P Maestrelli CE Mapp LM Fabbri CF Donner M Saetta 1998 Severity of airflow limitation is associated with severity of airway inflammation in smokers Am J Respir Crit Care Med 58 1277 1285
37. K Fujimoto M Yasuo K Urushibata M Hanaoka T Koizumi K Kubo 2005 Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease Eur Respir J 25 640 646 1:STN:280:DC%2BD2M7ntVKiug%3D%3D 10.1183/09031936.05.00047504 15802337 (Pubitemid 40528756)
38. T Yoshikawa G Dent J Ward G Angco G Nong N Nomura H Kazuto R Djukanovic 2007 Impaired neutrophil chemotaxis in chronic obstructive pulmonary disease Am J Respir Crit Care Med 175 473 479 10.1164/rccm.200507-1152OC 17110644 (Pubitemid 46354251)
39. C Gerard JL Frossard M Bhatia A Saluja NP Gerard B Lu M Steer 1997 Targeted disruption of the chemokine receptor CCR1 protects against pancreatitis associated lung injury J Clin Investig 8 2022 2027 10.1172/JCI119734
40. J Rottman A Slavin R Silva H Weiner C Gerard W Hancock 2000 Leukocyte recruitment during onset of allergic encephalomyelitis is CCR1 dependent Eur J Immunol 30 2372 2377 1:CAS:528:DC%2BD3cXlvFemsrw%3D 10.1002/1521-4141(2000)30: 8<2372::AID-IMMU2372>3.0.CO;2-D 10940928 (Pubitemid 30655773)
41. A Miller C Gerard M Schaller A Gruber A Humbles N Lukas 2006 Deletion of CCR1 attenuates pathophysiologic responses during respiratory syncytial virus infection J Immunol 176 2562 2567 1:CAS:528:DC%2BD28XpvV2qtQ%3D%3D 16456018 (Pubitemid 43201708)